Literature DB >> 15530670

Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity.

Sung-Soo Kim1, Hyun Woo Han, Unyeong Go, Hai Won Chung.   

Abstract

A catch-up campaign targeting children aged 8-16 years using measles-rubella (MR) vaccine was conducted during 2001 in Korea. To evaluate the impact of the campaign and assess mumps immunity, human IgG antibodies were detected using ELISA for measles (5826 samples) and mumps (5890 samples) in a national sample of opportunistically collected sera from a population aged 0-34 years. The measles immunity increased by 5-10% following the catch-up campaign in the targeted age group. Infants lost maternal antibodies rapidly and about 90% of infants were susceptible to measles and mumps at 6-8 months of life. The sero-prevalence of mumps antibody increased slowly with age and stabilized at a lower level when compared with that of measles. Despite an immediate reduction in susceptibility among the targeted age group of the catch-up campaign, continuous efforts to increase immunization coverage are needed to interrupt indigenous measles transmission. Furthermore, our results suggest continuous mumps outbreaks could occur because of the accumulation of susceptible individuals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530670     DOI: 10.1016/j.vaccine.2004.07.030

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia.

Authors:  A Tischer; N Andrews; G Kafatos; A Nardone; G Berbers; I Davidkin; Y Aboudy; J Backhouse; C Barbara; K Bartha; B Bruckova; A Duks; A Griskevicius; L Hesketh; K Johansen; L Jones; O Kuersteiner; E Lupulescu; Z Mihneva; M Mrazova; F De Ory; K Prosenc; F Schneider; A Tsakris; M Smelhausova; R Vranckx; M Zarvou; E Miller
Journal:  Epidemiol Infect       Date:  2007-03-30       Impact factor: 2.451

2.  Towards elimination: measles susceptibility in Australia and 17 European countries.

Authors:  Nick Andrews; Annedore Tischer; Annette Siedler; Richard G Pebody; Christopher Barbara; Suzanne Cotter; Arnis Duks; Nina Gacheva; Kriz Bohumir; Kari Johansen; Joel Mossong; Fernando de Ory; Katarina Prosenc; Margareta Sláciková; Heidi Theeten; Marios Zarvou; Adriana Pistol; Kalman Bartha; Dani Cohen; Jo Backhouse; Algirdas Griskevicius
Journal:  Bull World Health Organ       Date:  2008-03       Impact factor: 9.408

3.  Cross-sectional surveys of measles antibodies in the Jiangsu Province of China from 2008 to 2010: the effect of high coverage with two doses of measles vaccine among children.

Authors:  Yuanbao Liu; Peishan Lu; Ying Hu; Zhiguo Wang; Xiuying Deng; Fubao Ma; Hong Tao; Chengmei Jia; Xiaoyan Ding; Haitao Yang; Pei Liu; Jie Min
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

4.  Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020.

Authors:  Manoj V Murhekar; Nivedita Gupta; Alvira Z Hasan; Muthusamy Santhosh Kumar; V Saravana Kumar; Christine Prosperi; Gajanan N Sapkal; Jeromie Wesley Vivian Thangaraj; Ojas Kaduskar; Vaishali Bhatt; Gururaj Rao Deshpande; Ullas Padinjaremattathil Thankappan; Avi Kumar Bansal; Sanjay L Chauhan; Gangandeep Singh Grover; Arun Kumar Jain; Ragini N Kulkarni; Santanu Kumar Sharma; Itta K Chaaithanya; Sanchit Kharwal; Sunil K Mishra; Neha R Salvi; Sandeep Sharma; Nilanju P Sarmah; R Sabarinathan; Augustine Duraiswamy; D Sudha Rani; K Kanagasabai; Abhishek Lachyan; Poonam Gawali; Mitali Kapoor; Arpit Kumar Shrivastava; Saurabh Kumar Chonker; Bipin Tilekar; Babasaheb V Tandale; Mohammad Ahmad; Lucky Sangal; Amy Winter; Sanjay M Mehendale; William J Moss; Kyla Hayford
Journal:  Lancet Glob Health       Date:  2022-11       Impact factor: 38.927

5.  Seroprevalence of Measles Antibodies and Predictors for Seropositivity among Chinese Children.

Authors:  Xiaoqin Wang; Mei Ma; Zhaozhao Hui; Paul D Terry; Yue Zhang; Rui Su; Mingxu Wang; Wei Gu; Ling Li
Journal:  Int J Environ Res Public Health       Date:  2017-06-06       Impact factor: 3.390

6.  Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases.

Authors:  Hee Seung Hong; Jiwon Jung; Sang Hyoung Park; Hwa Jung Kim; Sung Wook Hwang; Dong-Hoon Yang; Jeong-Sik Byeon; Seung-Jae Myung; Suk-Kyun Yang; Byong Duk Ye
Journal:  Korean J Intern Med       Date:  2021-09-06       Impact factor: 2.884

7.  Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles/MMR immunization programme.

Authors:  Piyanit Tharmaphornpilas; Pornsak Yoocharean; Aim-Orn Rasdjarmrearnsook; Apiradee Theamboonlers; Yong Poovorawan
Journal:  J Health Popul Nutr       Date:  2009-02       Impact factor: 2.000

8.  Current status of measles in the Republic of Korea: an overview of case-based and seroepidemiological surveillance scheme.

Authors:  Young June Choe; Geun-Ryang Bae
Journal:  Korean J Pediatr       Date:  2012-12-20

9.  Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand.

Authors:  Romanee Chaiwarith; Jutarat Praparattanapan; Khanuengnit Nuket; Wilai Kotarathitithum; Khuanchai Supparatpinyo
Journal:  BMC Infect Dis       Date:  2016-04-30       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.